These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 9289806)
61. New steroids and new salicylates in inflammatory bowel disease: a critical appraisal. Campieri M Gut; 2002 May; 50 Suppl 3(Suppl 3):III43-6. PubMed ID: 11953332 [TBL] [Abstract][Full Text] [Related]
62. [Chronic inflammatory bowel diseases. Pathophysiology and drug therapy]. von Ritter C Radiologe; 1998 Jan; 38(1):3-7. PubMed ID: 9530772 [TBL] [Abstract][Full Text] [Related]
63. Glucocorticosteroid therapy in inflammatory bowel diseases: From clinical practice to molecular biology. Dubois-Camacho K; Ottum PA; Franco-Muñoz D; De la Fuente M; Torres-Riquelme A; Díaz-Jiménez D; Olivares-Morales M; Astudillo G; Quera R; Hermoso MA World J Gastroenterol; 2017 Sep; 23(36):6628-6638. PubMed ID: 29085208 [TBL] [Abstract][Full Text] [Related]
64. The safety of non-biological treatments in Ulcerative Colitis. Troncone E; Monteleone G Expert Opin Drug Saf; 2017 Jul; 16(7):779-789. PubMed ID: 28608717 [TBL] [Abstract][Full Text] [Related]
65. Dendritic cells in IBD pathogenesis: an area of therapeutic opportunity? Bates J; Diehl L J Pathol; 2014 Jan; 232(2):112-20. PubMed ID: 24122796 [TBL] [Abstract][Full Text] [Related]
66. [Therapeutic innovations in chronic inflammatory bowel diseases with "biological therapy"--anti-TNF and more]. Schölmerich J Internist (Berl); 2002 Nov; 43(11):1386-99. PubMed ID: 12524919 [No Abstract] [Full Text] [Related]
68. Clinical pharmacology in gastroenterology: development of new forms of treatment of inflammatory bowel disease. Brynskov J; Rasmussen SN Scand J Gastroenterol Suppl; 1996; 216():175-80. PubMed ID: 8726290 [TBL] [Abstract][Full Text] [Related]
69. Medical therapy for Crohn's disease: the state of the art. Stein RB; Lichtenstein GR Surg Clin North Am; 2001 Feb; 81(1):71-101, viii. PubMed ID: 11218170 [TBL] [Abstract][Full Text] [Related]
70. Aminosalicylates for the treatment of inflammatory bowel disease. Leichtner AM J Pediatr Gastroenterol Nutr; 1995 Oct; 21(3):245-52. PubMed ID: 8523207 [No Abstract] [Full Text] [Related]
71. [5-Aminosalicylic acid -- a new therapeutic possibility in chronic inflammatory intestinal disease?]. Roth W Leber Magen Darm; 1986 May; 16(3):176-8. PubMed ID: 3736310 [No Abstract] [Full Text] [Related]
72. Treatment of inflammatory bowel disease: safety and tolerability issues. Navarro F; Hanauer SB Am J Gastroenterol; 2003 Dec; 98(12 Suppl):S18-23. PubMed ID: 14697914 [TBL] [Abstract][Full Text] [Related]
77. Immunomodulatory benefits of cyclosporine A in inflammatory bowel disease. Kountouras J; Zavos C; Chatzopoulos D J Cell Mol Med; 2004; 8(3):317-28. PubMed ID: 15491507 [TBL] [Abstract][Full Text] [Related]
78. Drug utilization study in patients with Crohn's disease in Spain. Estiarte R; Juan J; Colomé E; Artés M; Jiménez FJ Eur J Gastroenterol Hepatol; 2003 Apr; 15(4):355-62. PubMed ID: 12655254 [TBL] [Abstract][Full Text] [Related]
79. Severe hypokalemia after budesonide treatment for Crohn's disease. Rosenbach Y; Zahavi I; Rachmal A; Dinari G J Pediatr Gastroenterol Nutr; 1997 Mar; 24(3):352-5. PubMed ID: 9138184 [No Abstract] [Full Text] [Related]
80. Budesonide for inflammatory bowel disease. Is it a magic bullet? Sachar DB N Engl J Med; 1994 Sep; 331(13):873-4. PubMed ID: 8078535 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]